On March 13, 2026, Personalis, Inc. announced the appointment of Richard Chen as the company's President, in addition to his existing roles as Executive Vice President of Research and Development and Chief Medical Officer. This decision was made by the board of directors based on a recommendation from the Chief Executive Officer, Christopher Hall, who previously held the position of President. Dr. Chen, who has been with the company since 2011, has a strong background in genomic data and medical informatics, holding degrees from Stanford University. In connection with his new role, Dr. Chen's annual base salary will increase to $570,000 effective April 1, 2026, and his performance bonus target will rise to 70% of his annual salary. Additionally, he will receive stock options and restricted stock units as part of his compensation package, which are set to vest over time. This leadership change is expected to enhance the company's strategic direction and operational execution in the competitive genomics market.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.